SMMT

Summit Therapeutics (SMMT) Market Capitalization Overview
Market Cap: $14.24B as of Nov 9, 2026
$14.24B
$199.44M (1.42%)past month
As of Nov 9, 2026, Summit Therapeutics (SMMT) has a market capitalization of $14.24B. Over the past 30 days, its market cap has decreased by -11.32%, while in the last 12 months, it has increased by 9.57%.
Market capitalization represents the total value of Summit Therapeutics as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.
Summit Therapeutics (SMMT) Market Cap Formula = Stock Price * Shares Outstanding
The market cap of Summit Therapeutics (SMMT) helps investors assess the company's size and compare it with competitors for better investment decisions.
Market capitalization represents the total value of Summit Therapeutics as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.
Summit Therapeutics (SMMT) Market Cap Formula = Stock Price * Shares Outstanding
The market cap of Summit Therapeutics (SMMT) helps investors assess the company's size and compare it with competitors for better investment decisions.
Summit Therapeutics (SMMT) Market Cap & Key Trends
See Summit Therapeutics’s latest market capitalization, historical trends, and financial insights with AI-powered fundamental data and custom analysis.
Start investing in Summit Therapeutics (SMMT)
Order type
Buy in
Order amount
Est. shares
0 shares
Summit Therapeutics (SMMT) Market Cap History
| Date | Market Cap | Change |
|---|---|---|
| Nov 2, 2026 | $11.81B | -11.32% |
| Oct 1, 2026 | $13.32B | +17.87% |
| Sep 1, 2026 | $11.30B | +8.55% |
| Aug 3, 2026 | $10.41B | -6.76% |
| Jul 1, 2026 | $11.17B | -8.37% |
| Jun 1, 2026 | $12.19B | -2.51% |
| May 1, 2026 | $12.50B | -11.29% |
| Apr 1, 2026 | $14.09B | +16.86% |
| Mar 2, 2026 | $12.06B | +15.15% |
| Feb 2, 2026 | $10.47B | -19.56% |
| Jan 2, 2026 | $13.02B | +1.51% |
Summit Therapeutics (SMMT) End of Year Market Cap History
| Date | Market Cap | Change |
|---|---|---|
| 2026 | $14.24B | +9.57% |
| 2025 | $12.99B | -1.25% |
| 2024 | $13.16B | +622.17% |
| 2023 | $1.83B | +112.88% |
| 2022 | $855.62M | +225.80% |
| 2021 | $262.63M | — |
FAQs About Summit Therapeutics (SMMT) Market Cap
As of Nov 9, 2026, the market capitalization of Summit Therapeutics (SMMT) is $14.24B. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.
In the last 30 days, Summit Therapeutics’s market capitalization has increased by 1.42%, changing from $14.04B to $14.24B as of Nov 9, 2026.
In the last 3 months, Summit Therapeutics’s market capitalization has increased by —, changing from – to – as of –.
In the year 2025, Summit Therapeutics’s market capitalization decreased from $13.16B in January to $12.99B in December, reflecting a -1.25% change.
In the past five years, Summit Therapeutics (SMMT) has had a compound annual growth rate (CAGR) of 118.20% in market capitalization. This means its market cap has grown at an average rate of 118.20% per year.
Summit Therapeutics (SMMT) Market Cap & Key Trends
See Summit Therapeutics’s latest market capitalization, historical trends, and financial insights with AI-powered fundamental data and custom analysis.
Start investing in Summit Therapeutics (SMMT)
Order type
Buy in
Order amount
Est. shares
0 shares
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.